HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine C Smith Selected Research

Dimethyl Sulfoxide (DMSO)

5/2006hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine C Smith Research Topics

Disease

22Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024 - 01/2012
7Neoplasms (Cancer)
12/2023 - 04/2012
4Leukemia
11/2023 - 01/2012
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2013 - 01/2011
2Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 01/2020
2Malaria
09/2014 - 11/2011
1Hypersensitivity (Allergy)
12/2023
1Cognitive Dysfunction
11/2023
1Frailty
11/2023
1Aneuploidy (Aneuploid)
12/2022
1Pain (Aches)
12/2021
1Headache (Headaches)
12/2021
1COVID-19
12/2021
1Postpartum Hemorrhage
08/2019
1Hypokalemia
05/2019
1Acidosis
05/2019
1Cardiac Arrhythmias (Arrythmia)
05/2019
1Ebola Hemorrhagic Fever
01/2018
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018
1Mucositis
06/2015
1Atrophy
06/2015
1Acute zonal occult outer retinopathy
06/2015
1Vomiting
09/2014
1Diarrhea
09/2014
1Fever (Fevers)
09/2014
1Peripheral Nervous System Diseases (PNS Diseases)
03/2014
1Eczema
01/2007
1Dyshidrotic Eczema (Pompholyx)
01/2007
1HIV Infections (HIV Infection)
01/2007
1Lymphoma (Lymphomas)
05/2006

Drug/Important Bio-Agent (IBA)

8Tyrosine Kinase InhibitorsIBA
03/2024 - 01/2011
7gilteritinibIBA
12/2022 - 01/2019
5fms-Like Tyrosine Kinase 3IBA
12/2023 - 01/2012
5Phosphotransferases (Kinase)IBA
11/2023 - 01/2012
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2022 - 06/2015
2Proteins (Proteins, Gene)FDA Link
11/2023 - 11/2021
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
12/2022 - 03/2016
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2022 - 01/2020
2midostaurinIBA
01/2022 - 12/2019
2pexidartinibIBA
01/2021 - 01/2020
2quizartinibIBA
01/2017 - 06/2015
1FF-10101IBA
03/2024
1CytokinesIBA
12/2023
1tyrosine receptor (receptor, tyrosine)IBA
11/2023
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2023
1venetoclaxIBA
12/2022
1ChromatinIBA
12/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2022
1VaccinesIBA
12/2021
1ChAdOx1 nCoV-19IBA
12/2021
1DNA (Deoxyribonucleic Acid)IBA
11/2021
1Cyclin D3IBA
01/2021
1ElectrolytesIBA
05/2019
1Saline SolutionIBA
05/2019
1MRX-2843IBA
03/2016
1c-Mer Tyrosine KinaseIBA
03/2016
1Etoposide (VP 16)FDA LinkGeneric
06/2015
1Fluorescein (Funduscein)FDA LinkGeneric
06/2015
1Retinaldehyde (Retinal)IBA
06/2015
1Busulfan (Busulfex)FDA Link
06/2015
1AntigensIBA
09/2014
1Antimalarials (Antimalarial Agents)IBA
09/2014
1ponatinibIBA
04/2013
1Imatinib Mesylate (Gleevec)FDA Link
11/2011
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
05/2006
1Methyl MethanesulfonateIBA
05/2006
1SolventsIBA
05/2006
1potassium bromateIBA
05/2006

Therapy/Procedure

15Therapeutics
03/2024 - 01/2007
5Drug Therapy (Chemotherapy)
11/2023 - 04/2013
2Cell Transplantation
11/2023 - 01/2020
2Stem Cell Transplantation
01/2018 - 06/2015
1Immunotherapy
11/2023
1Transplantation
01/2022
1Blood Transfusion (Blood Transfusions)
08/2019
1Hemodilution
05/2019
1Uterine Myomectomy
05/2019
1Hematopoietic Stem Cell Transplantation
06/2015
1Chemoprevention
11/2011